BBI
ELV icon

Baxter Bros Inc’s Elevance Health ELV Stock Holding History

Baxter Bros Inc’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-921
Closed -$323K – 172
2025
Q4 		$323K Hold
921
– – 0.04% 134
2025
Q3 		$298K Buy
+921
New +$286K 0.03% 143
2025
Q1 		– Sell
-868
Closed -$320K – 153
2024
Q4 		$320K Sell
868
-240
-22% -$100K 0.04% 127
2024
Q3 		$576K Sell
1,108
-1
-0.1% -$534 0.07% 100
2024
Q2 		$601K Sell
1,109
-200
-15% -$106K 0.08% 94
2024
Q1 		$679K Buy
1,309
+25
+2% +$12.4K 0.09% 93
2023
Q4 		$605K Buy
1,284
+184
+17% +$85.1K 0.08% 97
2023
Q3 		$479K Buy
+1,100
New +$499K 0.07% 103

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Baxter Bros Inc's ELV Position: Q1 2026 in Review

Baxter Bros Inc sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 921 shares — an estimated $323K sold.

Baxter Bros Inc first reported a position in ELV in Q3 2023 and held it in 8 quarters. The position peaked at $679K in Q1 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Baxter Bros Inc reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Baxter Bros Inc sold 921 Elevance Health shares in Q1 2026, an estimated $323K.
  • Baxter Bros Inc first reported a position in Elevance Health in Q3 2023 and held it in 8 quarters.
  • Baxter Bros Inc's Elevance Health position peaked at $679K in Q1 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Baxter Bros Inc's 13F filing for Q1 2026, filed 28 Apr 2026.